Log in to save to my catalogue

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808671971

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

About this item

Full title

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2016-06, Vol.30 (6), p.1237-1245

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Genetic and epigenetic aberrations contribute to the initiation and progression of acute myeloid leukemia (AML). GFI1, a zinc-finger transcriptional repressor, exerts its function by recruiting histone deacetylases to target genes. We present data that low expression of
GFI1
is associated with an inferior prognosis of AML patients. To elucida...

Alternative Titles

Full title

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808671971

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808671971

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/leu.2016.11

How to access this item